128 related articles for article (PubMed ID: 28123867)
1. NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution.
Messaoudene M; Fregni G; Enot D; Jacquelot N; Neves E; Germaud N; Garchon HJ; Boukouaci W; Tamouza R; Chanal J; Avril MF; Toubert A; Zitvogel L; Rusakiewicz S; Caignard A
Oncoimmunology; 2016; 5(12):e1154251. PubMed ID: 28123867
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer.
Fend L; Rusakiewicz S; Adam J; Bastien B; Caignard A; Messaoudene M; Iribarren C; Cremer I; Marabelle A; Borg C; Semeraro M; Barraud L; Limacher JM; Eggermont A; Kroemer G; Zitvogel L
Oncoimmunology; 2017; 6(1):e1163456. PubMed ID: 28197362
[TBL] [Abstract][Full Text] [Related]
3. NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.
Rusakiewicz S; Perier A; Semeraro M; Pitt JM; Pogge von Strandmann E; Reiners KS; Aspeslagh S; Pipéroglou C; Vély F; Ivagnes A; Jegou S; Halama N; Chaigneau L; Validire P; Christidis C; Perniceni T; Landi B; Berger A; Isambert N; Domont J; Bonvalot S; Terrier P; Adam J; Coindre JM; Emile JF; Poirier-Colame V; Chaba K; Rocha B; Caignard A; Toubert A; Enot D; Koch J; Marabelle A; Lambert M; Caillat-Zucman S; Leyvraz S; Auclair C; Vivier E; Eggermont A; Borg C; Blay JY; Le Cesne A; Mir O; Zitvogel L
Oncoimmunology; 2017; 6(1):e1137418. PubMed ID: 28197361
[TBL] [Abstract][Full Text] [Related]
4. Non-fitness status of peripheral NK cells defined by decreased NKp30 and perforin, and increased soluble B7H6, in cervical cancer patients.
Gutierrez-Silerio GY; Bueno-Topete MR; Vega-Magaña AN; Bastidas-Ramirez BE; Gutierrez-Franco J; Escarra-Senmarti M; Pedraza-Brindis EJ; Peña-Rodriguez M; Ramos-Marquez ME; Delgado-Rizo V; Banu N; Alejandre-Gonzalez AG; Fafutis-Morris M; Haramati J; Del Toro-Arreola S
Immunology; 2023 Mar; 168(3):538-553. PubMed ID: 36271832
[TBL] [Abstract][Full Text] [Related]
5. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.
Delahaye NF; Rusakiewicz S; Martins I; Ménard C; Roux S; Lyonnet L; Paul P; Sarabi M; Chaput N; Semeraro M; Minard-Colin V; Poirier-Colame V; Chaba K; Flament C; Baud V; Authier H; Kerdine-Römer S; Pallardy M; Cremer I; Peaudecerf L; Rocha B; Valteau-Couanet D; Gutierrez JC; Nunès JA; Commo F; Bonvalot S; Ibrahim N; Terrier P; Opolon P; Bottino C; Moretta A; Tavernier J; Rihet P; Coindre JM; Blay JY; Isambert N; Emile JF; Vivier E; Lecesne A; Kroemer G; Zitvogel L
Nat Med; 2011 Jun; 17(6):700-7. PubMed ID: 21552268
[TBL] [Abstract][Full Text] [Related]
6. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
[TBL] [Abstract][Full Text] [Related]
7. First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue.
Shemesh A; Tirosh D; Sheiner E; Tirosh NB; Brusilovsky M; Segev R; Rosental B; Porgador A
Front Immunol; 2015; 6():189. PubMed ID: 26082773
[TBL] [Abstract][Full Text] [Related]
8. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46.
Spaggiari GM; Carosio R; Pende D; Marcenaro S; Rivera P; Zocchi MR; Moretta L; Poggi A
Eur J Immunol; 2001 Jun; 31(6):1656-65. PubMed ID: 11385609
[TBL] [Abstract][Full Text] [Related]
9. Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity.
Shemer-Avni Y; Kundu K; Shemesh A; Brusilovsky M; Yossef R; Meshesha M; Solomon-Alemayehu S; Levin S; Gershoni-Yahalom O; Campbell KS; Porgador A
Front Immunol; 2017; 8():161. PubMed ID: 28261217
[TBL] [Abstract][Full Text] [Related]
10. Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer.
Han B; Mao FY; Zhao YL; Lv YP; Teng YS; Duan M; Chen W; Cheng P; Wang TT; Liang ZY; Zhang JY; Liu YG; Guo G; Zou QM; Zhuang Y; Peng LS
J Immunol Res; 2018; 2018():6248590. PubMed ID: 30255106
[TBL] [Abstract][Full Text] [Related]
11. Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46.
Bloushtain N; Qimron U; Bar-Ilan A; Hershkovitz O; Gazit R; Fima E; Korc M; Vlodavsky I; Bovin NV; Porgador A
J Immunol; 2004 Aug; 173(4):2392-401. PubMed ID: 15294952
[TBL] [Abstract][Full Text] [Related]
12. Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30).
Mavoungou E; Bouyou-Akotet MK; Kremsner PG
Clin Exp Immunol; 2005 Feb; 139(2):287-96. PubMed ID: 15654827
[TBL] [Abstract][Full Text] [Related]
13. TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.
Ivagnès A; Messaoudene M; Stoll G; Routy B; Fluckiger A; Yamazaki T; Iribarren K; Duong CPM; Fend L; Caignard A; Cremer I; LeCesne A; Adam J; Honoré C; Mir O; Chaigneau L; Berger A; Validire P; Christidis C; Brun-Ly VL; Smyth MJ; Mariette X; Salomon BL; Kroemer G; Rusakiewicz S; Zitvogel L
Oncoimmunology; 2018; 7(12):e1386826. PubMed ID: 30524877
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
[TBL] [Abstract][Full Text] [Related]
15. Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancy.
El Costa H; Casemayou A; Aguerre-Girr M; Rabot M; Berrebi A; Parant O; Clouet-Delannoy M; Lombardelli L; Jabrane-Ferrat N; Rukavina D; Bensussan A; Piccinni MP; Le Bouteiller P; Tabiasco J
J Immunol; 2008 Sep; 181(5):3009-17. PubMed ID: 18713971
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.
Semeraro M; Rusakiewicz S; Minard-Colin V; Delahaye NF; Enot D; Vély F; Marabelle A; Papoular B; Piperoglou C; Ponzoni M; Perri P; Tchirkov A; Matta J; Lapierre V; Shekarian T; Valsesia-Wittmann S; Commo F; Prada N; Poirier-Colame V; Bressac B; Cotteret S; Brugieres L; Farace F; Chaput N; Kroemer G; Valteau-Couanet D; Zitvogel L
Sci Transl Med; 2015 Apr; 7(283):283ra55. PubMed ID: 25877893
[TBL] [Abstract][Full Text] [Related]
17. NKp30 isoforms in patients with chronic hepatitis C virus infection.
Mantovani S; Mele D; Oliviero B; Barbarini G; Varchetta S; Mondelli MU
Immunology; 2015 Oct; 146(2):234-42. PubMed ID: 26094914
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell mediated immunosurveillance of pediatric neuroblastoma.
Semeraro M; Rusakiewicz S; Zitvogel L; Kroemer G
Oncoimmunology; 2015 Nov; 4(11):e1042202. PubMed ID: 26451315
[TBL] [Abstract][Full Text] [Related]
19. Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
Queiroz GAN; Mascarenhas REM; Vieillard V; Andrade RL; Galvão-Castro B; Grassi MFR
BMC Infect Dis; 2019 May; 19(1):433. PubMed ID: 31101076
[TBL] [Abstract][Full Text] [Related]
20. NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells.
Foltz JA; Somanchi SS; Yang Y; Aquino-Lopez A; Bishop EE; Lee DA
Front Immunol; 2016; 7():521. PubMed ID: 27933061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
